CDH5 and cancer: CDH5 and VEGF are recognised mediators of tumour angiogenesis, a process required for invasion and metastasis of solid tumours (Weidner et al, 1991), and VEGF inhibitors have been approved for the treatment of advanced cancer (Longatto Filho et al, 2010).